97 related articles for article (PubMed ID: 58136)
1. Letter: Cholesterol biosynthesis inhibitor AY9944.
Lullman-Rauch R
Lab Invest; 1976 May; 34(5):537. PubMed ID: 58136
[No Abstract] [Full Text] [Related]
2. Effects of the cholesterol biosynthesis inhibitor ay9944 on organotypic cultures ofmouse spinal cord. Retarded myelinogenesis and induction of cytoplasmic inclusions.
Kim SU
Lab Invest; 1975 Jun; 32(6):720-8. PubMed ID: 50497
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of myelin isolated from brains of young and adult rats treated with an inhibitor of cholesterol biosynthesis].
Rawlins FA; López-Jiménez C
Acta Cient Venez; 1979; 30(6):551-8. PubMed ID: 95381
[No Abstract] [Full Text] [Related]
4. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis. II. AY-9944 and AY-9944 plus zuclomiphene.
Ramsey RB; Fredericks M
Biochem Pharmacol; 1977 Jun; 26(12):1169-73. PubMed ID: 70208
[No Abstract] [Full Text] [Related]
5. Increment in sodium and potassium dependent adenosine triphosphatase of brain microsomal fraction from rats treated with the cholesterol biosynthesis inhibitor AY 9944.
Proverbio F; Rawlins FA
Mol Pharmacol; 1978 Sep; 14(5):911-9. PubMed ID: 82201
[No Abstract] [Full Text] [Related]
6. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in utero to a distal inhibitor of cholesterol biosynthesis.
Gofflot F; Gaoua W; Bourguignon L; Roux C; Picard JJ
Dev Dyn; 2001 Feb; 220(2):99-111. PubMed ID: 11169843
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol.
Ramsey RB
Biochem Pharmacol; 1978; 27(12):1637-40. PubMed ID: 81057
[No Abstract] [Full Text] [Related]
8. Niemann-Pick disease experimental model: sphingomyelinase reduction induced by AY-9944.
Sakuragawa N; Sakuragaw M; Kuwabara T; Pentchev PG; Barranger JA; Brady RO
Science; 1977 Apr; 196(4287):317-9. PubMed ID: 66749
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of AY9944 and plasma LDL (or whole plasma) on lymphocyte blastic transformation.
Rampini C; Adriambinintsoa C; Barbu V; Maziere JC; Maziere C; Roux C
Biochem Pharmacol; 1989 Nov; 38(21):3887-91. PubMed ID: 2480790
[No Abstract] [Full Text] [Related]
10. Niemann-Pick disease-like inclusions caused by a hypocholesteremic agent.
Sakuragawa M
Invest Ophthalmol; 1976 Dec; 15(12):1022-7. PubMed ID: 62729
[TBL] [Abstract][Full Text] [Related]
11. Changes in brain hydrolytic enzyme activities in rats treated with cholesterol biosynthesis inhibitor, AY9944.
Igarashi M; Suzuki K; Chen SM
Brain Res; 1975 Jun; 90(1):97-114. PubMed ID: 48406
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of sterol and DNA synthesis in peripheral blood lymphocytes by AY9944.
Kay G; Wilce PA
Biochem Biophys Res Commun; 1983 Jan; 110(1):82-7. PubMed ID: 6188453
[TBL] [Abstract][Full Text] [Related]
13. [Incorporation of 3H-thymidine in Wistar rat embryos treated with AY 9944].
Roux C; Rapin J; Dupuis R; Aubry MM
C R Seances Soc Biol Fil; 1975; 169(1):24-6. PubMed ID: 52389
[TBL] [Abstract][Full Text] [Related]
14. EFFECT OF A NOVEL HYPOCHOLESTEROLEMIC AGENT, TRANS-1,4-BIS-(2-CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE (AY-9944) ON ADRENAL MORPHOLOGY.
MARTON AV; GRESELIN E; GIVNER M; VOITH K
Endocrinology; 1964 Oct; 75():469-76. PubMed ID: 14211888
[No Abstract] [Full Text] [Related]
15. The effect of the hypocholesteremic drug, AY 9944 on the synthesis of bile salts in rat liver.
Botham KM; Boyd GS
Eur J Biochem; 1981 Sep; 118(3):501-5. PubMed ID: 6170514
[TBL] [Abstract][Full Text] [Related]
16. Colorimetric estimate of cholesterogenesis in livers perfused in the presence of trans-1,4-bis-(2-chlorobenzylaminomethyl)-cyclohexane dihydrochloride (AY-9944).
Goh EH
Biochem Pharmacol; 1979 Oct; 28(19):2969-72. PubMed ID: 92992
[No Abstract] [Full Text] [Related]
17. AY9944 inhibits early activation of phosphatidylinositol metabolism in concanavalin A-stimulated lymphocytes.
Rampini C
Biochem Pharmacol; 1990 Sep; 40(6):1417-9. PubMed ID: 1698368
[No Abstract] [Full Text] [Related]
18. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
Fliesler SJ; Richards MJ; Miller C; Peachey NS
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
[TBL] [Abstract][Full Text] [Related]
19. [Cholesterol and development].
Roux C; Wolf C; Llirbat B; Kolf M; Mulliez N; Taillemite JL; Cormier V; Le Merrer M; Chevy F; Citadelle D
C R Seances Soc Biol Fil; 1997; 191(1):113-23. PubMed ID: 9181133
[TBL] [Abstract][Full Text] [Related]
20. [Experimental Niemann-Pick rat: additional studies on the specificity of the sphingomyelinase reduction in rats treated with AY 9944 (author's transl)].
Watanabe K; Sakuragawa N; Arima M
No To Shinkei; 1981 Jun; 33(3):585-93. PubMed ID: 6167277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
